Stocktoria

Dolby Laboratories, Inc. DLB

NYSE · stock · Patent Owners & Lessors · website · IPO 2005-02-17

Dolby Laboratories, Inc. (DLB) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.50% (safety: moderate). FY2025 revenue was $1.3B at a 18.9% net margin.

Chart by TradingView
73/100
Stocktoria Quality Score · grade A
5/9
Piotroski F — financial health
9.78
Altman Z″ — distress risk · safe
1.5%
Dividend yield 5y avg · moderate · Dividend payout 49.6%
-2.77
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 5 4 6 6 6 5 4 6 5 2016201720182019202020212022202320242025
Altman Z″
12.02 11.78 10.87 10.57 11.46 11.99 11.21 9.55 9.00 9.78 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$61.39 as of 2026-08-01 · -14.4% 1y
$52.58$72.3752-wk

Beneish M-score: -2.77 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$5.1B
P / E19.8×
Dividend yield 5y avg1.5%
Net margin 5y avg18.8%
Return on equity 5y avg9.8%
Beta0.8
Employees2,051

Analyst price target

$78.33 +27.6% vs last
consensus: buy · 3 analysts
target range $60.00 – $90.00 · median $85.00
1 strong buy · 2 buy · 1 hold
Recent analyst actions
DateFirmRating
2026-06-15Barrington ResearchOutperform (main)
2026-06-11RosenblattBuy (main)
2026-04-27Barrington ResearchOutperform (main)
2026-01-30Barrington ResearchOutperform (main)
2026-01-30RosenblattBuy (main)
2026-01-26Barrington ResearchOutperform (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net sold -$2.7M on the open market · 12 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies

Piotroski Fstronger than 70%
Net marginstronger than 63%
Return on equitystronger than 60%
Revenue growthstronger than 48%

Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.294
Retained earnings / assets0.816
EBIT / assets0.082
Equity / liabilities4.417

Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
DLBDolby Laboratories, Inc.5/99.7819.8+5.9%
IDCCInterDigital, Inc.6/98.0617.5-4%
APPSDigital Turbine, Inc.7/9-1.81+15.2%
ACTGACACIA RESEARCH CORP8/95.6720.9+133.2%
JYNTJOINT Corp3/90.99+5.2%
RMCORoyalty Management Holding Corp3/94.94
XELBXCel Brands, Inc.3/9-9.95

All Finance, Insurance & Real Estate companies →

About Dolby Laboratories, Inc.

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

FAQ

Is DLB financially healthy?

Dolby Laboratories, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does DLB pay a dividend, and is it safe?

Yes. Dolby Laboratories, Inc. pays a dividend yielding about 2.50% with a 49.6% payout ratio, rated “moderate” for safety.

How profitable is DLB?

In FY2025, Dolby Laboratories, Inc. had a net margin of 18.9% and a return on equity of 9.7%.

Is DLB overvalued or undervalued?

Dolby Laboratories, Inc. trades at about 23.4× trailing earnings — below its 10-year norm (10-year range 25.3×–176.4×, median 29.7×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for DLB?

The average Wall-Street price target for Dolby Laboratories, Inc. is $78.33, about 27.6% above the recent price, from 3 analysts (consensus: buy).

Is DLB a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Dolby Laboratories, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 19.8×, a dividend yield of 2.50%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-09-26. Facts plus Stocktoria's own computed scores — not investment advice.